Cancer immune control needs senescence induction by interferon-dependent cell cycle regulator pathways in tumours

Journal: Nature Communications

Published: 2020-03-12

DOI: 10.1038/s41467-020-14987-6

Affiliations: 15

Authors: 35

Go to article
Institutions Share
Department of Dermatology, Uni Tübingen, Germany 0.37
Institute of Molecular Immunology (IMI), HMGU, Germany 0.09
Institute of Medical Genetics and Applied Genomics, Uni Tübingen, Germany 0.09
Cluster of Excellence - Image-Guided and Functionally Instructed Tumor Therapies (iFIT), Uni Tübingen, Germany 0.06
University Hospital Tübingen (UKT), Uni Tübingen, Germany 0.06
Helmholtz Zentrum München - German Research Center for Environmental Health (HMGU), Germany 0.06
Department of Medicine II, JMU, Germany 0.06
German Consortium of Translational Cancer Research (DKTK), Germany 0.04
Department of Preclinical Imaging and Radiopharmacy, Uni Tübingen, Germany 0.04
Werner Siemens Imaging Center, Uni Tübingen, Germany 0.04
Institute for Clinical Epidemiology and Applied Biometry, Uni Tübingen, Germany 0.03
CeGaT GmbH, Germany 0.03
Institute of Pathology and Neuropathology, Uni Tübingen, Germany 0.01
Clinic for Dermatology, UDE, Germany 0.01
West German Cancer Center, UDE, Germany 0.01

Return

Except where otherwise noted © 2020 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER